ROCHE has announced the launch of the Elecsys Troponin T high sensitive (TnT hs) assay, for use on Cobas and Modular Analytics serum work areas, in the UK and Ireland.
This highly sensitive diagnostic assay has been developed to improve the detection and exclusion of myocardial injury in the early stages, demonstrating excellent precision in the range of 0.003-10 ng/ml Troponin T in serum or plasma, and to help identify risk of future coronary events. “Cardiac troponins have revolutionised our ability to diagnose AMI,” commented Dr Richard Body, emergency medicine specialist at Manchester Royal Infirmary, “but until recently assays were limited by a lack of sensitivity at the time of presentation and a lack of precision at the lower concentrations above the 99th percentile. The Elecsys TnT hs assay has the potential to address both of these issues.”
